Evidence map›Paper›PMID 42545035›Full record

ArticleEmerging microbes & infections2026

Carbapenemase-producing

Inès Rezzoug, Océane Vanparis, Joséphine Poiraud, Subidsha Nandakumaran, Delphine Girlich, Léna Latour, Haniel Defoi, Cécile Emeraud, Agnès B Jousset, Aurelien Birer and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Emerging microbes & infections, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Antimicrobial Resistance Profile ofAntibiotics (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Inès RezzougDepartment of Bacteriology-Hygiene, Bicêtre Hospital, Assistance Publique-Hôpitaux de Paris, Le Kremlin-Bicêtre, France.
Océane VanparisFrench National Reference Center for Antibiotic Resistance, Le Kremlin-Bicêtre, France.
Joséphine PoiraudDepartment of Bacteriology-Hygiene, Bicêtre Hospital, Assistance Publique-Hôpitaux de Paris, Le Kremlin-Bicêtre, France.
Subidsha NandakumaranDepartment of Bacteriology-Hygiene, Bicêtre Hospital, Assistance Publique-Hôpitaux de Paris, Le Kremlin-Bicêtre, France.
Delphine GirlichTeam 'Resist' UMR1184 'Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB)', Faculty of Medicine, INSERM, Université Paris-Saclay, CEA, LabEx LERMIT, Le Kremlin-Bicêtre Cedex, France.
Léna LatourDepartment of Bacteriology-Hygiene, Bicêtre Hospital, Assistance Publique-Hôpitaux de Paris, Le Kremlin-Bicêtre, France.
Haniel DefoiDepartment of Bacteriology-Hygiene, Bicêtre Hospital, Assistance Publique-Hôpitaux de Paris, Le Kremlin-Bicêtre, France.
Cécile EmeraudDepartment of Bacteriology-Hygiene, Bicêtre Hospital, Assistance Publique-Hôpitaux de Paris, Le Kremlin-Bicêtre, France.
Agnès B JoussetDepartment of Bacteriology-Hygiene, Bicêtre Hospital, Assistance Publique-Hôpitaux de Paris, Le Kremlin-Bicêtre, France.
Aurelien BirerFrench Associated National Reference Center for Antibiotic Resistance, Bacteriology, CHU Gabriel-Montpied, Clermont-Ferrand, France.
Benoit PilmisTeam 'Resist' UMR1184 'Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB)', Faculty of Medicine, INSERM, Université Paris-Saclay, CEA, LabEx LERMIT, Le Kremlin-Bicêtre Cedex, France.
Aymeric JacqueminTeam 'Resist' UMR1184 'Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB)', Faculty of Medicine, INSERM, Université Paris-Saclay, CEA, LabEx LERMIT, Le Kremlin-Bicêtre Cedex, France.
Rémy A BonninDepartment of Bacteriology-Hygiene, Bicêtre Hospital, Assistance Publique-Hôpitaux de Paris, Le Kremlin-Bicêtre, France.
Laurent DortetDepartment of Bacteriology-Hygiene, Bicêtre Hospital, Assistance Publique-Hôpitaux de Paris, Le Kremlin-Bicêtre, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study analysed a large French collection of carbapenemase-producing

methodsWe conducted a retrospective study of all KoC isolates received at the French National Reference Center for Antimicrobial Resistance from 2017 to 2023. Whole-genome sequencing was performed to assess species assignment, phylogeny, and sequence types. Virulence analyses included biofilm formation assays (on abiotic surfaces and eukaryotic cells) and

results

conclusionOur findings confirm that

Indexed as

Bacterial Proteinsbeta-LactamasesBiofilmsKlebsiella InfectionsKlebsiella oxytocaAnimalsAnti-Bacterial AgentsFranceHumansMolecular EpidemiologyMothsPhenotypePhylogenyRetrospective StudiesVirulenceAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemasebiofilmCarbapenemasesEnterobacteralesepidemiologyKlebsiella oxytocavirulenceβ-lactamase

Identifiers

PMID42545035
PMCPMC13508490

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.